Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methotrexate measurement |
Component |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate injection into tubal pregnancy |
Direct substance |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate poisoning |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Accidental methotrexate poisoning |
Causative agent |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
Intentional methotrexate poisoning |
Causative agent |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
forgiftning med methotrexat, uvist med hvilken hensigt |
Causative agent |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate adverse reaction |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Allergy to methotrexate |
Causative agent |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
Methotrexate overdose |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Accidental methotrexate overdose |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Intentional methotrexate overdose |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
overdosis af methotrexat, uvist med hvilken hensigt |
Causative agent |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Plasma methotrexate measurement |
Component |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
2 |
Serum methotrexate measurement |
Component |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
2 |
methotrexat 2,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
Methotrexate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 2,5 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 40 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 100 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 100 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 12,5 mg/ml infusionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 12,5 mg/ml infusionsvæske, opløsning, hætteglas a 60 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
Methotrexate excretion measurement (procedure) |
Component |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 7,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 15 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat LPF 25 mg/ml, til injektion (uden konserveringsmiddel) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
Product containing methotrexate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate sodium (substance) |
Is a |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
Neurotoxicity caused by methotrexate (disorder) |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Accidental methotrexate poisoning |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Intentional methotrexate poisoning |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Intravenous injection of methotrexate (procedure) |
Direct substance |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate skin ulceration (disorder) |
Causative agent |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
Intramuscular injection of methotrexate (procedure) |
Direct substance |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Intravenous injection of methotrexate (procedure) |
Direct substance |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Intravenous injection of methotrexate (procedure) |
Direct substance |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Intramuscular injection of methotrexate (procedure) |
Direct substance |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate injection into tubal pregnancy |
Direct substance |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Measurement of methotrexate in cerebrospinal fluid (procedure) |
Component |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
2 |
Subcutaneous injection of methotrexate (procedure) |
Direct substance |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Subcutaneous injection of methotrexate (procedure) |
Direct substance |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Allergy to methotrexate |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing methotrexate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Cirrhosis of liver caused by methotrexate (disorder) |
Causative agent |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
3 |
methotrexat 2,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 2,5 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 5 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 7,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 7,5 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 15 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 15 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate 25mg/mL conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
|
methotrexat 5 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 2,5 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 7,5 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
methotrexat 15 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 5 milligram/2 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 500 milligram/20 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 1 gram/40 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 1 gram/10 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 5 gram/50 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 50 milligram/2 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 200 milligram/8 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 5 gram/200 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate sodium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
|
Methotrexate-associated lymphoproliferative disorders are rare immunodeficiency-associated lymphoproliferative diseases characterized by lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients. |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing only methotrexate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing only methotrexate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate (as methotrexate sodium) 100 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate (as methotrexate sodium) 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate skin ulceration (disorder) |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Cirrhosis of liver caused by methotrexate (disorder) |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Cirrhosis of liver caused by methotrexate (disorder) |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
2 |
Accelerated rheumatoid nodulosis caused by methotrexate (disorder) |
Causative agent |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
2 |
Methotrexate (as methotrexate sodium) 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 15 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate (as methotrexate sodium) 20 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate (as methotrexate sodium) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methotrexate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate 50 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate 50 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Methotrexate therapy (procedure) |
Direct substance |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Measurement of methotrexate in cerebrospinal fluid (procedure) |
Component |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |
Serum methotrexate measurement |
Component |
True |
Methotrexate (substance) |
Inferred relationship |
Some |
1 |